Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Journal of Global Oncology|September 23, 2018
Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström MacroglobulinemiaShebli Atrash, Qing Zhang, Xenofon Papanikolaou, et al.Expert Opinion on Biological Therapy|August 5, 2020
Daratumumab subcutaneous formulation for the treatment of multiple myelomaBarry Paul, Issam Hamadeh, Shebli Atrash, et al.The American Journal of Case Reports|April 10, 2013
Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosisAl-Ola Abdallah, Christopher Westfall, Harry Brown, et al.Expert Review of Hematology|July 14, 2020
An evaluation of subcutaneous daratumumab for the treatment of multiple myelomaBarry Paul, Shebli Atrash, Manisha Bhutani, et al.Leukemia|November 29, 2019
Extramedullary multiple myelomaManisha Bhutani, David M Foureau, Shebli Atrash, et al.Current Oncology (Toronto, Ont.)|September 26, 2025
CAR-T Access Disparities for Multiple Myeloma in the Midwest: A Social Determinants of Health PerspectiveMichael Weise, Shebli Atrash, Briha Ansari, et al.Cancers|June 10, 2023
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed TherapyShebli Atrash, Aytaj Mammadzadeh, Fulei Peng, et al.Clinical Lymphoma, Myeloma & Leukemia|October 14, 2020
Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple MyelomaAl-Ola Abdallah, Ghulam Rehman Mohyuddin, Zahra Mahmoudjafari, et al.Journal of Hematology|March 10, 2023
Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and DexamethasoneOmar Alkharabsheh, Polina Bellman, Zahra Mahmoudjafari, et al.Blood Cancer Journal|March 24, 2022
Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysisShebli Atrash, Evelyn M Flahavan, Tao Xu, et al.Pageof 9